Deiodinase activity is present in Xenopus laevis during early embryogenesis

被引:77
作者
Dubois, Ghislaine Morvan
Sebillot, Anthony
Kuiper, George G. J. M.
Verhoelst, Carla H. J.
Darras, Veerle M.
Visser, Theo J.
Demeneix, Barbara A.
机构
[1] Museum Natl Hist Nat, CNRS, UMR 5166, Dept Regulat Dev & Mol Divers, F-75231 Paris 05, France
[2] Erasmus MC, Dept Internal Med, NL-3015GE Rotterdam, Netherlands
[3] Katholieke Univ Leuven, Lab Comparat Endocrinol, B-3000 Louvain, Belgium
[4] Museum Natl Hist Nat, Watchfrog SAS, F-75231 Paris, France
关键词
D O I
10.1210/en.2006-0609
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thyroid hormones orchestrate amphibian metamorphosis. The type 2 and type 3 deiodinases make vital contributions to this process by controlling levels of the thyroid hormones T-4 and T-3 available to different tissues. Because the tadpole thyroid gland is not functional until stage NF44, it has been widely assumed that thyroid signaling is absent during amphibian early development, thyroid hormone only becoming a major regulator during premetamorphic stages. Similarly, in mammals, thyroid function is known to be essential to neuronal development, especially during the perinatal stages, but again little is known about early stages of development. Here we demonstrate that key elements of thyroid hormone signaling are present during early development of Xenopus. In particular, we find functional thyroid hormone-activating deiodinases and significant levels of their substrates, T-4 and T-3, during early embryogenesis. Furthermore, we have further characterized a recently identified deiodinase in amphibians, homologous to mammalian type 1 deiodinase (D1). This enzyme is expressed in marked, spatially defined patterns during embryogenesis. The patterns of expression of type 1 deiodinase are distinct from those of type 2 and type 3 deiodinases. Deiodinase expression is found in neurogenic areas from stage NF30 onward, both in the central and peripheral nervous systems. We conclude that both activating and inactivating deiodinases show dynamic patterns of expression during early embryogenesis in amphibians, particularly in neurogenic areas. These findings suggest that thyroid hormone signaling is a key component of early neuronal development in vertebrates.
引用
收藏
页码:4941 / 4949
页数:9
相关论文
共 41 条
  • [1] THE THYROID-HORMONE RECEPTOR GENE (C-ERBA-ALPHA) IS EXPRESSED IN ADVANCE OF THYROID-GLAND MATURATION DURING THE EARLY EMBRYONIC-DEVELOPMENT OF XENOPUS-LAEVIS
    BANKER, DE
    BIGLER, J
    EISENMAN, RN
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (10) : 5079 - 5089
  • [2] The type 2 and type 3 iodothyronine deiodinases play important roles in coordinating development in Rana catesbeiana tadpoles
    Becker, KB
    Stephens, KC
    Davey, JC
    Schneider, MJ
    Galton, VA
    [J]. ENDOCRINOLOGY, 1997, 138 (07) : 2989 - 2997
  • [3] Action of thyroid hormone in brain
    Bernal, J
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2002, 25 (03) : 268 - 288
  • [4] Perspectives in the study of thyroid hormone action on brain development and function
    Bernal, J
    Guadaño-Ferraz, A
    Morte, B
    [J]. THYROID, 2003, 13 (11) : 1005 - 1012
  • [5] Thyroid hormones and brain development
    Bernal, J
    [J]. VITAMINS AND HORMONES - ADVANCES IN RESEARCH AND APPLICATIONS, VOL 71, 2005, 71 : 95 - +
  • [6] BERRY MJ, 1993, AM J CLIN NUTR, V57, P249
  • [7] The role of deiodinases in amphibian metamorphosis
    Brown, DD
    [J]. THYROID, 2005, 15 (08) : 815 - 821
  • [8] Expression of type II iodothyronine deiodinase marks the time that a tissue responds to thyroid hormone-induced metamorphosis in Xenopus laevis
    Cai, LQ
    Brown, DD
    [J]. DEVELOPMENTAL BIOLOGY, 2004, 266 (01) : 87 - 95
  • [9] CLONING OF A THYROID HORMONE-RESPONSIVE RANA-CATESBEIANA C-ERBA-BETA GENE
    DAVEY, JC
    SCHNEIDER, MJ
    GALTON, VA
    [J]. DEVELOPMENTAL GENETICS, 1994, 15 (04): : 339 - 346
  • [10] Maternal thyroid hormones early in pregnancy and fetal brain development
    de Escobar, GM
    Obregón, MJ
    del Rey, FE
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 18 (02) : 225 - 248